Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 300.5234
- Book/Share 61.1499
- PB 1.0956
- Debt/Equity 1.0557
- CurrentRatio 0.8227
- ROIC 0.0403
- MktCap 84553936800.0
- FreeCF/Share 4.7113
- PFCF 14.2323
- PE 15.9631
- Debt/Assets 0.3178
- DivYield 0.0398
- ROE 0.0698
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
New June Fortune 500 Industry Leaders Show 3 Ideal "Safer" Dividend Buys
Published: June 20, 2025 by: Seeking Alpha
Sentiment: Positive
Three Fortune 500 Industry Leaders—Energy Transfer, Verizon, and World Kinect—currently meet the 'dogcatcher' ideal of fair price and safer dividends. Analyst targets project 21% to 50% net gains for the top ten F500IL dividend dogs by June 2026, with average gains of 28.8%. Most top-yielding F500IL stocks remain overpriced, but a 60% market correction or dividend increases could make all ten fairly priced for income investors. Twelve F500IL stocks have negative free cash flow margins, making them unsafe for dividends; focus on the three 'safer' fair-priced options for now.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: June 19, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
Two Healthcare Heavyweights, One Winner: UnitedHealth or CVS Health?
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS gains steam as rising margins, strong Medicare results, and cost cuts set it apart from UNH.
Read More
Exploring CVS' Health Services Segment: A Key Growth Engine for 2025?
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.
Read More
5 Low Price-to-Book Value Stocks That You Can Buy in June
Published: June 17, 2025 by: Zacks Investment Research
Sentiment: Positive
The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.
Read More
3 Medical Services Stocks Capitalizing on the Healthcare AI Boom
Published: June 16, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS, BTSG and WGS are three medical services stocks tapping into AI and tech-driven care to boost diagnostics, cut costs and drive growth in 2025.
Read More
4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil
Published: June 16, 2025 by: Zacks Investment Research
Sentiment: Positive
As geopolitical risks jolt markets, STNE, CNC, CVS and PFE shine with low cash flow valuations and solid earnings outlooks.
Read More
CVS Health's MBR Improves: Can It Sustain Amid Elevated Cost Trends?
Published: June 12, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS posts its first favorable MBR in quarters, but elevated cost trends test its ability to sustain the gains.
Read More
CVS vs. DHR: Which Stock Should Value Investors Buy Now?
Published: June 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Read More
5 Ideal 'Safe' Buys From June Fortune Return On Leadership Screen
Published: June 10, 2025 by: Seeking Alpha
Sentiment: Positive
Coincident to the June 5, 2025 annual launch of their Fortune 500, Fortune also partnered with Indiggo to measure Return On Leadership, called the ROL100. Arnold research focused on those 100 using YCharts 6/6/25 data on Dividends from 78, which hereafter are referred to as the Fortune Return on Leadership Dividend Dogs (FROLD). ReturnOnLeadership is based on four fundamental factors: Connection to Purpose, Strategic Clarity, Leadership Alignment, and Focused Action.
Read More
CVS Health Advances Digital Strategy: Is It the Next Revenue Pillar?
Published: June 05, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS unveils a $20B digital strategy to tackle healthcare gaps and reshape consumer health experiences.
Read More
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Top 4 Value Stocks to Buy as Trade Tensions Still Cloud H2 Outlook
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Positive
STNE, CNC, CVS and PFE stand out as top value picks amid trade tensions and a murky H2 economic outlook.
Read More
CVS Sues Arkansas Over Law Banning PBM Ownership Of Pharmacies
Published: May 29, 2025 by: Forbes
Sentiment: Negative
CVS Health Thursday sued the state of Arkansas, trying to thwart a law the healthcare company said would lead to the closure of all 23 CVS drugstores in the state.
Read More
5 Valuable Price-to-Book Stocks to Strengthen Your Portfolio
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and PSFE are some such stocks.
Read More
CVS or DHR: Which Is the Better Value Stock Right Now?
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Read More
Avoid These Dividend Disasters Before It's Too Late
Published: May 23, 2025 by: Seeking Alpha
Sentiment: Negative
Dividend stocks are facing many big risks. The high interest rates, trade war, and AI revolution could lead to many dividend cuts. I discuss what this all means for dividend investors.
Read More
Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
UnitedHealth, CVS Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Published: May 22, 2025 by: Benzinga
Sentiment: Negative
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 50 points on Thursday.
Read More
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
2 Dividend Stocks That are Holding Their Own in 2025
Published: May 17, 2025 by: 24/7 Wall Street
Sentiment: Positive
Perhaps it's not all too surprising to witness the S&P 500 run into turbulence after two of the best years for stock gains in recent memory.
Read More
Here's Why CVS Health (CVS) Looks Ripe for Bottom Fishing
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS Health (CVS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Read More
CVS bids for Rite Aid stores, Bloomberg News reports
Published: May 15, 2025 by: Reuters
Sentiment: Positive
Healthcare conglomerate CVS Health has bid for a significant number of stores and patient data from bankrupt pharmacy chain operator Rite Aid, Bloomberg News reported on Thursday.
Read More
UNH Stock Vs. CVS Stock
Published: May 15, 2025 by: Forbes
Sentiment: Negative
Health insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year citing higher medical costs. This comes during a challenging time when the CEO Andrew Witty also stepped down for ‘personal reasons.
Read More
5 Low Price-to-Book Value Stocks to Buy in May
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and SAN are some such stocks.
Read More
4 Value Picks to Ride the Market Rebound After US-China Trade Thaw
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. STNE, CNC, CVS & PFE boast a low P/CF ratio.
Read More
CVS Health celebrates reopening of Hendersonville store destroyed by Hurricane Helene
Published: May 12, 2025 by: PRNewsWire
Sentiment: Neutral
The South Main Street CVS Pharmacy is again providing health, wellness and pharmacy services to customers and patients WOONSOCKET, R.I. , May 12, 2025 /PRNewswire/ -- Today, leaders from CVS Health® (NYSE: CVS) were joined by state and local representatives to celebrate the reopening of one of its Hendersonville CVS Pharmacy stores.
Read More
Levi & Korsinsky Investigates Possible Securities Fraud Violations by CVS Health Corporation (CVS)
Published: May 12, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CVS Health Corporation ("CVS Health Corporation") (NYSE:CVS) concerning possible violations of federal securities laws. The U.S. Department of Justice filed a complaint on May 1, 2025, against insurance broker organizations, including CVS, alleging that "insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments in the insurers' Medicare Advantage plans.
Read More
CVS Health: Big 2025 Momentum, Strong Growth Ahead, Shares Underpriced
Published: May 11, 2025 by: Seeking Alpha
Sentiment: Positive
CVS Health has shown impressive year-to-date performance, driven by strong Q1 results and strategic shifts in its business model. I reiterate a buy rating on CVS due to its low valuation, mixed technicals, and promising earnings growth prospects. Key catalysts include improved performance in Healthcare Benefits, higher star ratings in Medicare Advantage, and strategic exits from less profitable areas.
Read More
CVS vs. DHR: Which Stock Is the Better Value Option?
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical Services sector might want to consider either CVS Health (CVS) or Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO Mr. J. David Joyner CEBS
- Employees 219000